Tag: Anticoagulants
Fewer Major Bleeds With Once- Versus Twice-Daily Enoxaparin
In propensity analysis, patients on enoxaparin once daily had fewer bleeds, fewer deaths at 15, 30 days
Lower Inpatient Costs for Dabigatran, Rivaroxaban in A-Fib
Lower inpatient costs with dabigatran, rivaroxaban versus warfarin for newly diagnosed atrial fibrillation
Many Ischemic Stroke Survivors Not Prescribed Anticoagulants
Reasons for not prescribing OAC include fall risk, poor prognosis, bleeding history, older age, dementia
Continuing Warfarin Protective After Diagnosis of Dementia
Findings in cohort of veterans aged 65 years or older receiving warfarin for nonvalvular atrial fibrillation
PPI Cuts Risk of Warfarin-Related Upper GI Bleeding
Greatest reduction in risk seen for patients also taking antiplatelet drugs or NSAIDs
Single-Dose LMWH Can Interfere With Algorithm for DVT Diagnosis
Single dose given the previous day can reduce D-dimer and risk incorrectly ruling out DVT
Stroke, A-Fib Recurrence Low at One Year After AF Ablation
No difference in atrial fibrillation recurrence for patients with versus without stroke
OSA Is Risk Factor for Recurrent Pulmonary Embolism
For patients who stop oral anticoagulants for a first episode of PE, OSA is risk factor for recurrence
Dabigatran May Be Better Than Warfarin After Bleeding Episode
Resuming any anticoagulant found safer than stopping the drugs in these cases
AHA: Many A-Fib Patients Not Receiving Oral Anticoagulants
Only 46 percent of patients with indications received OACs at discharge from hospital
